| Results summary | View all lists in GO:BiolProc | View all genes in C02A.profile.ud50 |
|
The covalent alteration of one or more monomeric units in a polypeptide, polynucleotide, polysaccharide, or other biological polymer, resulting in a change in its properties. enrichment: 1.56-fold |
![]() |
||||||||||||
| Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
| 216079_AT | EPM2A | D | E | P | epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) | ||||||||
| 217173_S_AT | LDLR | T | E | P | low density lipoprotein receptor (familial hypercholesterolemia) | ||||||||
| 202067_S_AT | LDLR | T | E | P | low density lipoprotein receptor (familial hypercholesterolemia) | ||||||||
| 202068_S_AT | LDLR | T | E | P | low density lipoprotein receptor (familial hypercholesterolemia) | ||||||||
| 207884_AT | GUCY2D | P | S | guanylate cyclase 2D, membrane (retina-specific) | |||||||||
| 205231_S_AT | EPM2A | D | E | P | epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) | ||||||||
| 203942_S_AT | MARK2 | D | P | S | MAP/microtubule affinity-regulating kinase 2 | ||||||||
| 204101_AT | MTM1 | D | E | P | myotubularin 1 | ||||||||
| 205327_S_AT | ACVR2A | G | D | P | S | activin A receptor, type IIA | |||||||
| 206267_S_AT | MATK | G | D | P | S | megakaryocyte-associated tyrosine kinase | |||||||
| 210129_S_AT | TTLL3 | P | tubulin tyrosine ligase-like family, member 3 | ||||||||||
| 203101_S_AT | MGAT2 | E | P | mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase | |||||||||
| 214969_AT | MAP3K9 | P | S | mitogen-activated protein kinase kinase kinase 9 | |||||||||
| 212991_AT | FBXO9 | P | F-box protein 9 | ||||||||||
| 212781_AT | RBBP6 | P | retinoblastoma binding protein 6 | ||||||||||
| 212249_AT | PIK3R1 | G | D | X | E | P | S | phosphoinositide-3-kinase, regulatory subunit 1 (p85 alpha) | |||||
| 203792_X_AT | PCGF2 | D | P | R | polycomb group ring finger 2 | ||||||||